Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
about
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.The sports psychiatrist and performance-enhancing drugs.Annual banned-substance review: Analytical approaches in human sports drug testing.Nonoperative treatment of muscle injuries - recommendations from the GOTS expert meeting.
P2860
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
@en
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
@nl
type
label
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
@en
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
@nl
prefLabel
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
@en
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle.
@nl
P2860
P50
P1476
Actovegin, a non-prohibited drug increases oxidative capacity in human skeletal muscle
@en
P2093
Stine D Søndergård
P2860
P304
P356
10.1080/17461391.2015.1130750
P577
2016-01-08T00:00:00Z